India’s fight against chronic pain just got a powerful new weapon. FlexifyMe, the healthtech startup that made waves on Shark Tank India, has raised a whopping Rs 20 crore to scale its AI-driven physiotherapy platform — and it wants to make back pain, neck stiffness, and shoulder aches a thing of the past.
The Startup That’s Taking on India’s Back Pain Epidemic
Founded in 2021 by Manjeet Singh and Amit Bhayani, FlexifyMe isn’t just another health app. It promises a scientific, AI-backed solution to one of the biggest lifestyle problems plaguing Indians: chronic musculoskeletal pain.
Instead of temporary fixes, the platform uses AI-powered posture and motion analysis to uncover the root cause of pain and pairs patients with licensed physiotherapists who create tailor-made treatment plans.
The result? A data-driven path to recovery that feels more like science and less like guesswork.
How FlexifyMe Works
- Starts with AI scanning posture and movement to detect hidden imbalances
- Matches users with expert physiotherapists for personalized sessions
- Offers live one-on-one physiotherapy, guided video programs, and online yoga
- Tracks every bit of progress with measurable outcomes
In other words, FlexifyMe is making physiotherapy smarter, faster, and measurable.
Rs 20 Crore to Power the Next Big Leap
The fresh Rs 20 crore funding will help FlexifyMe double down on growth. Here’s what’s coming next:
- Hybrid care expansion with both online and offline centers
- Posture and gait labs for advanced scientific assessments
- Stronger clinical research collaborations to keep treatments evidence-backed
According to co-founder Manjeet Singh, this is about more than funding: “We’re building the future of physiotherapy. Millions of people live with pain unnecessarily — we’re here to change that.”
A Shark Tank Success Story
FlexifyMe grabbed headlines when it appeared on Shark Tank India Season 3, bagging investment from Emcure’s Namita Thapar. Before that, it had already secured $1 million from Flipkart Ventures, giving it the firepower to refine its AI tech.
Now, with Rs 20 crore in fresh funding, the startup is gearing up to take its mission nationwide.
Why This Matters
Back pain and musculoskeletal disorders aren’t just an inconvenience — they’re one of the top causes of disability worldwide. Millions of Indians silently suffer, often resorting to painkillers or invasive surgeries.
FlexifyMe’s solution offers a non-invasive, scientific, and accessible way to fight chronic pain. It’s not just for patients either — the company also works with enterprises, insurers, and healthcare ecosystems to make recovery mainstream.
What’s Next for FlexifyMe
The roadmap is clear: more AI, more clinics, and more lives changed. By combining cutting-edge tech with human expertise, FlexifyMe wants to make physiotherapy cool, modern, and — above all — effective.
And if it succeeds, it could redefine how India (and eventually the world) approaches pain management.
The Bottom Line
From Shark Tank stage lights to raising Rs 20 crore, FlexifyMe’s rise has been anything but ordinary. With its bold AI-first approach, the startup isn’t just treating pain — it’s declaring war on it.
The question is no longer whether AI can change healthcare. It’s whether FlexifyMe can lead that revolution.
